News
ARV-102 achieved greater than 50% LRRK2 reduction in the CSF and greater than 90% LRRK2 reduction in the peripheral blood mononuclear cells (PBMCs), indicating substantial central and peripheral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback